Navigation Links
Arthrosurface Launches World's First Talus Resurfacing Implant for the Ankle
Date:10/24/2011

FRANKLIN, Mass., Oct. 24, 2011 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has launched its HemiCAP® Talus Resurfacing System for damage to the ankle in Europe and other international markets.  Prior to commercialization, the HemiCAP® Talus System was tested by well known Foot and Ankle surgeons throughout Europe in a four year clinical evaluation. The company reports that results from over 100 implantations indicated a very high level of patient satisfaction.

Prof. Dr. C. Niek van Dijk, Department of Orthopaedic Surgery, Academic Medical Center, University of Amsterdam, said "Metallic implantation with the HemiCAP® system offers a promising new solution for those patients who have failed their primary treatment. For these young and active patients it is important to restore the damaged area in order to protect the underlying bone and prevent further cyst formation.  I am very encouraged by our clinical results over the last four years."

Focal defects of the talar dome are often caused by trauma and result in deep, cup-shaped lesions. This incongruity of the joint surface and resulting cartilage damage often alters contact stresses in the ankle joint and can likely lead to development of painful cysts deep within the bone.  As pain sensing nerves exist in the bone, it is these cysts and fluid pressure on areas of exposed bone that can cause significant pain and debilitation.

Dr. Ned Amendola, Professor of Orthopaedics and Director of Sports Medicine at the University of Iowa, said "The HemiCAP® Talus Resurfacing System allows surgeons to restore the damaged surface of the talar dome by reproducing three surfaces with one implant, namely the dome, ridge and medial wall. In our study we showed that the HemiCAP® Talus System re-approximates the native geometry of the talar dome providing a load sharing surface to help protect the remaining rim of good cartilage."

The company reports that previous alternatives available to patients after failing primary treatment were to opt for total ankle replacements or ankle fusions.  Each of these options are associated with compromises for the patient as an ankle replacement removes a significant amount of bone and has a higher risk of failure than other joint replacements and fusion permanently eliminates the movement of the ankle joint. The company boasts that the HemiCAP® Talus implant now gives patients another option that is significantly less invasive, preserves the joint and allows for normal activity.

The Arthrosurface HemiCAP® Talus System is part of its Focal to Total Joint Platform Technology that offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the contours of the patients' joint surface as measured at the time of surgery.


'/>"/>
SOURCE Arthrosurface, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthrosurface Continues to Expand into Fast Growing Shoulder Market
2. Arthrosurface® Hits the 20,000 Implant Milestone
3. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
4. Prometheus Launches Next Generation IBD Diagnostic Test
5. Market Education Tactics and Strategies to Support Successful Oncology Product Launches
6. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
7. TRACE Launches Leading Edge Anti-Bribery Compliance Software
8. Boston Scientific Launches Promus Element™ Stent System In China
9. Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S.
10. Masimo Launches the 2011 Radical-7 with rainbow® Acoustic Monitoring and In Vivo Adjustment™
11. Darah Medical Awarded GSA Schedule, Launches Online Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology:
(Date:4/30/2017)... ... April 30, 2017 , ... TransLiquid Cartoon is a ... X. Editors can pick and choose from a variety of liquid transitions that ... shadows using simple color swabs. Utilize on-screen controls to fully manipulate transitions through ...
(Date:4/29/2017)... Aliso Viejo, CA (PRWEB) , ... April 29, 2017 , ... ... effects. Seamlessly transition from one video to the next without having to set ... bleeding, ripping, and blasting transitions to enhance your video production. , TransDark features dynamic ...
(Date:4/28/2017)... ... 2017 , ... An April 24th article on Yahoo! Beauty discusses the case of ... of a weight loss surgery. The woman, declaring “I will not hate my body anymore!” ... her dramatic weight loss. Dr. Feiz & Associates notes that, while it often refers its ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will ... begins with the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of ... the following ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on ... or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, ...
Breaking Medicine News(10 mins):